Bifidobacterium lactis inhibits NF-κB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice

Seung Won Kim, Hee Man Kim, Kyoung Min Yang, Sun Ah Kim, Sung Kyu Kim, Min Ji An, Jae Jun Park, Sang Kil Lee, Tae Il Kim, Won Ho Kim, Jae Hee Cheon

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Background: The aim of this study was to investigate the anti-inflammatory effects of Bifidobacterium lactis on intestinal epithelial cells (IECs) and on experimental acute murine colitis and its tumor prevention effects on colitis-associated cancer (CAC) in mice. Methods: Human HT-29 cells were stimulated with IL-1β, lipopolysaccharides, or tumor necrosis factor-α with and without B. lactis, and the effects of B. lactis on nuclear factor kappa B (NF-κB) signaling in IEC were examined. For in vivo study, dextran sulfate sodium (DSS)-treated mice were fed with and without B. lactis. Finally, we induced colonic tumors in mice by azoxymethane (AOM) and DSS and evaluated the effects of B. lactis on tumor growth. Results: B. lactis significantly suppressed NF-κB activation, including NF-κB-binding activity and NF-κB-dependent reporter gene expression in a dose-dependent manner, and suppressed IκBα degradation, which correlated with the downregulation of NF-κB-dependent gene products. Moreover, B. lactis suppressed the development of acute colitis in mice. Compared with the DSS group, the severity of DSS-induced colitis as assessed by disease activity index, colon length, and histological score was reduced in the B. lactis-treated group. In the CAC model, the mean number and size of tumors in the B. lactis-treated group were significantly lower than those in the AOM group. Conclusions: Our data demonstrate that B. lactis inhibits NF-κB and NF-κB-regulated genes in IEC and prevents acute colitis and CAC in mice. These results suggest that B. lactis could be a potential preventive agent for CAC as well as a therapeutic agent for inflammatory bowel disease.

Original languageEnglish
Pages (from-to)1514-1525
Number of pages12
JournalInflammatory Bowel Diseases
Volume16
Issue number9
DOIs
Publication statusPublished - 2010 Sep

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Gastroenterology

Fingerprint Dive into the research topics of 'Bifidobacterium lactis inhibits NF-κB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice'. Together they form a unique fingerprint.

  • Cite this